[Changes in the heparinocyte count during intake of hormonal contraceptives].
D000328:Adult; D000367:Age Factors; D001491:Basophils / Q000187:drug effects*; D002128:Calcium Metabolism Disorders / Q000139:chemically induced; D002715:Chlormadinone Acetate / Q000009:adverse effects; D003276:Contraceptives, Oral / Q000009:adverse effects*; D004338:Drug Combinations; D004997:Ethinyl Estradiol / Q000009:adverse effects; D005260:Female; D006025:Glycosaminoglycans / Q000378:metabolism; D006493:Heparin / Q000096:biosynthesis; D006494:Heparin Antagonists; D006801:Humans; D007958:Leukocyte Count; D008407:Mast Cells; D008598:Menstruation; D008656:Mestranol / Q000009:adverse effects; D009640:Norethindrone / Q000009:adverse effects; D010060:Ovulation; D011247:Pregnancy; D013923:Thromboembolism / Q000139:chemically induced*
D003276:Contraceptives, Oral; D004338:Drug Combinations; D006025:Glycosaminoglycans; D006494:Heparin Antagonists; D002715:Chlormadinone Acetate; D004997:Ethinyl Estradiol; D006493:Heparin; D008656:Mestranol; D009640:Norethindrone
Veränderungen der Heparinozytenzahl bei Einnahme von hormonalen Kontrazeptiva.